Thioredoxin 1 epitope and monoclonal antibody specifically binding thereto
US-2024248090-A1 · Jul 25, 2024 · US
US10725033B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10725033-B2 |
| Application number | US-201715802120-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 2, 2017 |
| Priority date | Jan 31, 2012 |
| Publication date | Jul 28, 2020 |
| Grant date | Jul 28, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Assays used in conjunction with a thermal contrast reader are disclosed. In the assay, the test strip includes materials that can develop a thermal response if a target analyte is present in a sample. Linear flow assays include nanoparticles with high affinity binding to the analyte. Binding of the nanoparticles with an analyte in the sample is detected using thermal contrast. Analytes over a broad range of concentrations are detected in the linear flow assays. Methods of detecting target analytes and kits comprising lateral flow assays and thermal contrast reader are also disclosed.
Opening claim text (preview).
What is claimed is: 1. A method of enhancing the analytical performance of a lateral flow assay comprising: optimizing the size and shape of nanoparticles in a lateral flow assay, wherein the optimizing comprises analyzing the binding affinity of an analyte to the nanoparticles coated with analyte binding molecules and the diffusion and convection of the nanoparticles to a test region in a membrane of the lateral flow assay and wherein the analyzing comprises measuring the thermal response of the nanoparticles by a thermal sensor in response to an energy signal applied by an energy source and wherein the thermal sensor is an infrared sensor. 2. The method of claim 1 wherein the lateral flow assay comprises test dots in a test region. 3. The method of claim 1 wherein the concentration range of the lateral flow assay for detecting the analyte in a sample is between about 10 −5 mg/L and about 310 mg/L. 4. The method of claim 1 , wherein the thermal response comprises the absorption properties of the nanoparticles and the scattering properties of the nanoparticles, and wherein the absorption properties and the scattering properties determine the optimal size and shape of the nanoparticles in the assay. 5. The method of claim 1 , wherein the energy source applied comprises laser excitation and the sensor comprises an infrared camera. 6. The method of claim 1 , wherein the analyte in the assay is detected over a range of 3 orders of magnitude or more. 7. The method of claim 1 , wherein the analyte in the assay is detected over a range of 6 orders of magnitude or more. 8. The method of claim 1 , wherein the concentration range of the assay for detecting the analyte in a sample is between about 3 log 10 and about 7 log 1o. 9. The method of claim 1 wherein the nanoparticles are between about 10 nm and about 400 nm.
based on lateral flow · CPC title
with calorimetric detection, e.g. with thermal lens detection · CPC title
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change · CPC title
Photothermal radiometry with measurement of emission · CPC title
from Mycobacteriaceae (F) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.